Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II
Bertram Pitt(Bayer (Germany)), Balasamy Thiyagarajan(United States Military Academy), George Klinger(United States Military Academy), Marvin A. Konstam(Tufts Medical Center), Felipe A Martinez(Instituto Médico DAMIC), Philip A. Poole‐Wilson(Mario Negri Institute for Pharmacological Research), James D. Neaton(University of Minnesota), Kenneth Dickstein, Robert Segal(United States Military Academy), A. John Camm(St George's, University of London), Günter A.J. Riegger(University Hospital Regensburg), Divakar Sharma(United States Military Academy)
Cited by 1,960
Related Papers
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|Survey of Anesthesiology|2000|2.9k